Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Amobarbital D5 (ethyl D5)

Amobarbital D5 (ethyl D5)

1190003-63-4

DISCOVER
Anthranilic Acid-alpha-13C DRUG PRECURSOR

Anthranilic Acid-alpha-13C DRUG PRECURSOR

335080-98-3

DISCOVER
Anthranilic-3,4,5,6 D4 Acid DRUG PRECURSOR

Anthranilic-3,4,5,6 D4 Acid DRUG PRECURSOR

60124-83-6

DISCOVER
Antipyrine D3 (N-methyl D3)

Antipyrine D3 (N-methyl D3)

65566-62-3

DISCOVER
Aripiprazole D8 (butyl D8)

Aripiprazole D8 (butyl D8)

1089115-04-7

DISCOVER
(S)-Amlodipine

(S)-Amlodipine

103129-82-4

DISCOVER
Amiodarone

Amiodarone

1951-25-3

DISCOVER
4-Aminobenzamide

4-Aminobenzamide

2835-68-9

DISCOVER
Albendazole sulfone-(methyl D3)

Albendazole sulfone-(methyl D3)

1448345-60-5

DISCOVER
Alendronic Acid

Alendronic Acid

66376-36-1

DISCOVER
Atomoxetine HCl

Atomoxetine HCl

82248-59-7

DISCOVER
Alimemazine tartrate

Alimemazine tartrate

4330-99-8

DISCOVER